As of Dec 15
| 0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for Cross Country Healthcare Inc have a median target of 17.00, with a high estimate of 21.00 and a low estimate of 13.00. The median estimate represents a +31.17% increase from the last price of 12.96.
The current consensus among 8 polled investment analysts is to Buy stock in Cross Country Healthcare Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.